InvestorsHub Logo
Followers 0
Posts 107
Boards Moderated 0
Alias Born 03/07/2017

Re: RedSox04 post# 739

Tuesday, 01/02/2018 3:14:08 AM

Tuesday, January 02, 2018 3:14:08 AM

Post# of 1318
As of Friday HADV or Health Advance is in Good Standing on OTCMakets.com or the Pinksheets again.

Its a NEW Year, New Management, I am looking forward to a great year and some updates on

Cebidiofen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464442

and

Polyoxyfen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464423)

The potential use of this for Opiate withdrawal OR an alternative to Opiates in the first place is epic, BOTH is even better.

I personally dont see them on the Pinks long, its a great place for venture and other initial capital raises but long term the next step of course is migrate and uplist or get bought out by a major after clinical trials and the other usual process are initiated or completed.

In my opinion, Any way you look at HADV, the "UPSIDE Potential" is great!!